• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Catalytic Asymmetric anti-Selective Nitroaldol Reaction En Route to Zanamivir

tetano

Editor, Senior Moderator
Angew Chem Int Ed Engl. 2012 Jan 10. doi: 10.1002/anie.201108153. [Epub ahead of print]
Catalytic Asymmetric anti-Selective Nitroaldol Reaction En Route to Zanamivir.
Nitabaru T, Kumagai N, Shibasaki M.
Source

Institute of Microbial Chemistry, Tokyo, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021 (Japan) http://www.bikaken.or.jp/research/group/shibasaki/shibasaki-lab/index_e.html; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033 (Japan).
Abstract

Battling the flu: Zanamivir (Relenza) is widely prescribed as an anti-influenza drug. It contains a vicinal amino alcohol, which is in an anti orientation, and is readily accessed by an anti-selective catalytic asymmetric nitroaldol (Henry) reaction promoted by a heterobimetallic complex (see scheme; PMB=p-methoxybenzyl). Additional synthetic manipulation of the nitroaldol product allowed the enantioselective synthesis of zanamivir.

Copyright ? 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

PMID:
22234923
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22234923
 
Back
Top Bottom